Ftss v. anglaise

SECTION 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE COMPANY/UNDERTAKINGTrade Name Xstrata Zinc Canada, General Smelting Company of Canada, 1400 Norman Street, Lachine (Québec), Canada H8S 1A8 SECTION 2. HAZARDS IDENTIFICATIONWHMIS (Canada) Hazard classes (categories)/Hazard statements None Hazards words SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Name SECTION 4. FIRST-AID MEASURES Eye contact Remove contact lenses if present. Rinse eyes with plenty of water. Call a physician. IF INHALED : Remove victim to fresh air and keep at rest in a position comfortable for breathing. Induce vomiting. Rinse mouth. UNCONSCIOUS person : DO NOT induce vomiting or give any liquid. SECTION 5. FIRE-FIGHTING MEASURES Flash point Dust : Flammable when exposed to heat or flames. Indium : Flammable dust when exposed to heat or flames. Mixtures of indium with sulfur : Ignite when heated. Not explosive (Mechanical impact ; Static discharge) Indium : Reacts explosively with : Dinitrogen tetraoxide + acetonitrile. NON-FLAMMABLE. Use fire fighting materials and procedures adapted to the immediate environment. Firefighters must wear ful protective clothing and self-contained breathing apparatus (SCBA). SECTION 6. ACCIDENTAL RELEASE MEASURES Measures Use appropriate tools to place spil ed materials in suitable containers for reclamation or disposal. High concentrations of fumes or dust or risk of emission of toxic material : Use a positive-pressure, self-contained breathing apparatus (SCBA) to avoid inhalation of material. Low concentrations : Use a NIOSH/OSHA approved ful face cartridge respirator or the equivalent. Ful protective clothing. Work gloves and boots. SECTION 7. HANDLING AND STORAGE Handling DO NOT ingest or inhale dust. Wear adequate protective clothing. Wear approved respirators if adequate ventilation cannot be provided. Ingestion or inhalation : Seek medical advice immediately and provide medical personnel with a copy of this SDS. Away from incompatible substances, heat or sources of ignition. SECTION 8. EXPOSURE CONTROLS/PERSONAL PROTECTION Note : Indium : NIOSH REL-TWA ( 10 hours) : 0.1 mg/m3 (REL also applies to other indium compounds, as In). SUBCUTANEOUS acute (LoLD) : 10 mg/kg (Mouse). (RTECS). Zinc : LD50 and LC50 : Not available. (RTECS). Consult local authorities for acceptable exposure limits Use process enclosures, local exhaust ventilation or other engineering controls to keep airborne levels below recommended exposure limits. Safety goggles. Coveralls. Work gloves and boots. Dust respirator. Be sure to use a NIOSH approved respirator or equivalent when concentrations exceed occupational exposure limits. SECTION 9. PHYSICAL AND CHEMICAL PROPERTIES Physical state and appearance Solid (Bar, ingot) SECTION 10. STABILITY AND REACTIVITY Stability Yes (Under normal conditions of ambiant temperature) Indium : Forms a violent reaction with mercury (I ) bromide at 350°C. React with : Mineral acids, oxidizers. Zinc : Ammonium nitrate, barium dioxide, barium dinitrate, chlorates, chlorides, fluorides, chlorine trifluoride, chromic trioxide, hydrazine mononitrate, hydroxylamine, performic acid, potassium nitrate, dipotassium peroxide, selenium, sodium peroxide, tellurium, sulfur, sodium hydroxide, nitrobenzene, oxidants ; Dust or very fine powder with water. SECTION 11. TOXICOLOGICAL INFORMATION Routes of entry Ingestion. Inhalation. Eyes and skin contact. Zinc : NOT A CARCINOGEN (IARC, OSHA, NTP) ; NOT LISTED (ACGIH). Indium : NOT LISTED (ACGIH, IARC). Indium : NIOSH REL-TWA ( 10 hours) : 0.1 mg/m3 (REL also applies to other indium compounds, as In). SUBCUTANEOUS acute (LoLD) : 10 mg/kg (Mouse). (RTECS). Solid form : No health hazards. Conditions and work practices which generate dust or fumes should be avoided or control ed. Zinc : Exposure to fumes or extremely fine dust may cause metal fume fever, a delayed, generally benign, transient, reversible flu-like condition. Possibility of toxic effects to : Blood, kidneys, lung and liver. Non-control ed repeated or prolonged exposure : Possibility of target organs damages : Eyes, skin, respiratory system, liver, kidneys, heart, blood. Indium : Low toxicity (Solid). Target organs for acute and chronic overexposure : Liver, kidneys, lungs. Eating, drinking and smoking must be prohibited in areas where this material is handled and processed. Wash hands and face before eating, drinking and smoking. SECTION 12. ECOLOGICAL INFORMATION Ecotoxicity Zinc : Rainbow trout (LC50, 96h) : 1.2 ppm ; (LC50, 48 h) 4.76 ppm ; Zebra fish (LC50, 48 h) : 136 ppm. Zinc : May be toxic to aquatic life. Low levels of zinc wil affect taste of water. SECTION 13. DISPOSAL CONSIDERATIONS Disposal methods Recycle to process, if possible. Discard the product or containers in ful compliance with Federal, Provincial and local regulations. SECTION 14. TRANSPORT INFORMATION TDG (Pictograms) SECTION 15. REGULATORY INFORMATION Labelling (GHS) Regulation (EC) No 1272/2008 CLP : Not listed. EU: Consolidated Inventories : Listed. Indium : EU Consolidated Inventories : numéro EC 231-180-0 Zinc : EU Consolidated Inventories : EC Number 231-175-3 Not classified in the Annex I of Directive 67/548/EEC Not listed in the Annex I of Council Regulation No (EC) 304/2003 Not listed in a priority list (as foreseen under Council Regulation (EEC) No 793/93 CANADIAN ENVIRONMENTAL PROTECTION ACT (CEPA) : on the Domestic Substances List (DSL) ; Acceptable for use under the provisions of CEPA. CERCLA Section 103 Hazardous substances (40 CFR 302.4) : Listed. Zinc (RQ) : *1 000 pounds (454 kg) TSCA (EPA, Toxic Substance Control Act) Chemical Inventory (40 CFR710) : Listed. TSCA (EPA, Toxic Substance Control Act) Chemical Inventory (40 CFR710) : Listed. Indium ; Zinc. * No declaration required if the diameter of the piece of solid metal released is equal to or exceeds 100 micrometers (0.004 inches). NFPA (National Fire Protection Association) (U.S.A.) Fire Hazard 1 SECTION 16. OTHER INFORMATION References - TLVs and BEIs (2010). Based on the Documentation of the Threshold Limit Values for Chemical Substances and Physical Agents & Biological Exposure Indices. ACGIH, Cincinnati, OH – http://www.acgih.org - CCOHS (2010) - Canadian Centre for Occupational Health and Safety - http://www.ccohs.ca/ - CSST (2010) - Commission de la Santé et de la Sécurité du Travail (Québec). Service du répertoire toxicologique - ESIS : C&L (Classification and Labelling), substances ou préparations selon la Directive 67/548/EEC (substances) et - ESIS : EINECS (European Inventory of Existing Commercial chemical Substances) O.J. C 146A, 15.6.1990 - ESIS : EINECS corrections publiées dans O.J. C 54/13 01.03.2002, 2002/C54/08. - Guidance on the Application of the CLP Criteria. Guidance to Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging (CLP) of substances and mixtures. 25/08/2009. ECHA Reference : ECHA-09-G-02-EN. European Chemicals Agency, 2009. - ERG (2008). Emergency Response Guidebook, U.S. Department of Transportation, Transport Canada, et le Secretariat of Communications and Transportation of Mexico - Guidance on the Application of the CLP Criteria. Guidance to Regulation (EC) No 1272/2008 on Classification, Labelling and Packaging (CLP) of substances and mixtures. 25/08/2009. ECHA Reference : ECHA-09-G-02-EN. European Chemicals Agency, 2009. - HSDB (2010) - Hazardous Substances Data Bank.Network of databases on toxicology, hazardous chemicals, and environmental health. NLM Databases & Electronic Resources, U.S. National Library of Medicine, NHI, 8600 Rockvil e Pike, Bethesda, MD 20894 - IARC - Monographs on the Evaluation of Carcinogenic Risks to Humans (col ection) - - Merck Index (1999). Merck & CO., Inc, 12th edition - NIOSH U.S. (2010) - Pocket Guide to Chemical Hazards - Patty's Industrial Hygiene and Toxicology, 3rd Revised Edition - Règlement sur les produits contrôlés (Canada) - REGULATION (EC) No 1272/2008 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing. Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006. (Text with EEA relevance). Official Journal of the European Union. L353 p1-1355, 1.12.2008. - RTECS (2010). Registry of Toxic Effects of Chemical Substances, NIOSH, CDC - Toxicologie industrielle & intoxication professionnelle, 3e édition, Lauwerys - TSCA (2010) - U.S. EPA Toxic Substance Control Act, Chemical Inventory. System of Registries (SoR), Substance Registry Services, http://iaspub.epa.gov/sor_internet/registry/substreg/searchandretrieve/substancesearch/search.do : Commission de la Santé et de la Sécurité du Travail (Québec). : International Agency for Research on Cancer. NIOSH : National Institute of Occupational Safety and Health. RTECS : Registry of Toxic Effects of Chemical Substances No specific studies have been performed on this mixture. For your protection, we suggest that you test it before using in your process. Rédigé par : Groupe STEM Consultants / Xstrata Zinc Canada Complete revision : 2010-12-07 Xstrata Zinc Canada, General Smelting Company of Canada, 1400 Norman Street, Lachine (Québec), Canada H8S 1A8 Notice to Reader Although reasonable precautions have been taken in the preparation of the data contained herein, it is offered solely for your information, consideration and investigation. Xstrata Zinc Canada extends no warranty and assumes no responsibility for the accuracy of the content and expressly disclaims al liability for reliance thereon. This material safety data sheet provides guidelines for the safe handling and processing of this product; it does not and cannot advise on al possible situations, therefore, your specific use of this product should be evaluated to determine if additional precautions are required. Individuals exposed to this product should read and understand this information and be provided pertinent training prior to working with this product.

Source: http://www.generalsmelting.ca/EN/MSDS/Documents/2010-Indium-zinc-alloy.pdf

newsmaker.com.au

The following treatment guidelines are based on the results of clinical studies and are provided for information purposes only. It is the operating ophthalmologist’s responsibility to familiarize themselves with the latest recommended techniques. Almost all patients with abnormally elevated IOP, which The treatment regimen is evolving and protocols vary may benefit from IOP reduction, are sui

Peri-operative pain control

R. A. Bellmont. DPodM, MChS. Brandon. Manitoba. Canada. Pain is an un-avoidable bi-product of any surgical procedure, whether it is a simple Partial Nail Avulsion or complicated Medial Column Fusion. Whatever Podiatric Surgeons do in order to help their patient, at sometime, pain will be experienced by our patient. We can’t simply ‘slap them on the face and tell them it’s all over’(1), as

Copyright © 2012-2014 Medical Theses